Olema Pharmaceuticals, Inc.

OLMANASDAQHealthcare● Active

$10.05

$-0.27(-2.57%)

Market Cap$877405346

P/E Ratio—

52W High$36.259

52W Low$3.89

Avg Volume1.5M

Open$10.40

Beta2.00

Insider Trades Ownership Employees

Olema Pharmaceuticals, Inc.（OLMA）内幕交易

基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。

SEC EDGAR · FMP · OLMA · 截至 2026年6月8日

活动摘要

买入笔数

P-Purchase only

卖出笔数

近12个月

买卖比

0.00

Buy/Sell (by trades)

整体情绪

偏空

↑ Buy 0%仅显示有效交易 · 排除RSU归属100% Sell ↓

Olema Pharmaceuticals, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale

截至 2026年6月8日

OLMA 季度内部人买卖趋势

OLMA 内幕交易卖出 · OLMA 内幕交易买入 · 季度活动

买入总量（含股权归属）卖出总量

7.0M3.5M0

2024 Q3

2024 Q4

2025 Q1

2025 Q2

2025 Q3

2025 Q4

2026 Q1

2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度

As of Jun 8, 2026

活跃内部人

近12个月交易最活跃 · OLMA CEO内幕交易

显示全部内部人 · 点击卡片过滤下方交易表

▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API

近期内幕交易记录

OLMA 高管卖出股份 · OLMA 董事内幕交易 · SEC Form 4申报

显示最近 45 条 · 普通股 · 仅Form 4

横向滑动查看全部列

日期	内部人	类型	股数	均价	总金额	交易后持股	申报
Mar 4, 2026	Mitchell Shawnte CHIEF LEGAL OFFICER	Option	25,000	$4.37	$109K	25,000	Form 4
Mar 3, 2026	Mitchell Shawnte CHIEF LEGAL OFFICER	Option	15,000	$4.37	$66K	15,000	Form 4
Mar 4, 2026	Mitchell Shawnte CHIEF LEGAL OFFICER	Sale	24,767	$24.25	$601K	233	Form 4
Mar 3, 2026	Mitchell Shawnte CHIEF LEGAL OFFICER	Sale	15,000	$23.01	$345K	0	Form 4
Feb 2, 2026	Austin Sasha Lu VP of Finance and Controller	Award	11,700	—	—	16,188	Form 4
Jan 20, 2026	Harmon Cyrus Director	Sale	10,000	$26.88	$269K	727,770	Form 4
Jan 14, 2026	Harmon Cyrus Director	Sale	3,489	$29.12	$102K	737,770	Form 4
Jan 13, 2026	Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF.	Sale	3,822	$28.01	$107K	239,727	Form 4
Jan 15, 2026	Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF.	Sale	100,000	$28.73	$2.87M⚡	139,727	Form 4
Jan 14, 2026	Myles David C. CH. DISCOV. & NON-CLIN DEV OFF	Option	50,000	$4.87	$244K	592,761	Form 4
Jan 14, 2026	Myles David C. CH. DISCOV. & NON-CLIN DEV OFF	Sale	14,997	$28.60	$429K	577,764	Form 4
Jan 13, 2026	Myles David C. CH. DISCOV. & NON-CLIN DEV OFF	Sale	49,800	$27.60	$1.37M⚡	542,961	Form 4
Jan 14, 2026	Myles David C. CH. DISCOV. & NON-CLIN DEV OFF	Sale	35,003	$28.99	$1.01M⚡	542,761	Form 4
Jan 13, 2026	Myles David C. CH. DISCOV. & NON-CLIN DEV OFF	Sale	200	$28.49	$6K	542,761	Form 4
Jan 12, 2026	Myles David C. CH. DISCOV. & NON-CLIN DEV OFF	Sale	10,000	$28.34	$283K	144,846	Form 4
Dec 26, 2025	Bohen Sean President and CEO · Director	Gift	8,500	—	—	237,650	Form 4
Dec 22, 2025	Harmon Cyrus Director	Sale	2,881	$28.53	$82K	741,259	Form 4
Dec 19, 2025	CLARK IAN T Director	Option	12,070	$4.08	$49K	264,800	Form 4
Dec 19, 2025	CLARK IAN T Director	Option	21,520	$7.84	$169K	252,730	Form 4
Dec 19, 2025	CLARK IAN T Director	Sale	29,904	$28.83	$862K	234,896	Form 4
Dec 19, 2025	CLARK IAN T Director	Option	21,520	$3.61	$78K	231,210	Form 4
Dec 19, 2025	CLARK IAN T Director	Option	209,690	$4.41	$924K	209,690	Form 4
Dec 19, 2025	CLARK IAN T Director	Sale	193,056	$29.71	$5.74M⚡	41,840	Form 4
Dec 19, 2025	CLARK IAN T Director	Sale	41,840	$30.48	$1.28M⚡	0	Form 4
Dec 19, 2025	Myles David C. CH. DISCOV. & NON-CLIN DEV OFF	Sale	1,225	$28.08	$34K	601,656	Form 4

Mitchell Shawnte

CHIEF LEGAL OFFICER

Option

日期

Mar 4

股数

25,000

均价

$4.37

总金额

$109K

View Form 4 on SEC.gov

Mitchell Shawnte

CHIEF LEGAL OFFICER

Option

日期

Mar 3

股数

15,000

均价

$4.37

总金额

$66K

View Form 4 on SEC.gov

Mitchell Shawnte

CHIEF LEGAL OFFICER

Sale

日期

Mar 4

股数

24,767

均价

$24.25

总金额

$601K

View Form 4 on SEC.gov

Mitchell Shawnte

CHIEF LEGAL OFFICER

Sale

日期

Mar 3

股数

15,000

均价

$23.01

总金额

$345K

View Form 4 on SEC.gov

Austin Sasha Lu

VP of Finance and Controller

Award

日期

Feb 2

股数

11,700

均价

—

总金额

—

View Form 4 on SEC.gov

Harmon Cyrus

Director

Sale

日期

Jan 20

股数

10,000

均价

$26.88

总金额

$269K

View Form 4 on SEC.gov

Harmon Cyrus

Director

Sale

日期

Jan 14

股数

3,489

均价

$29.12

总金额

$102K

View Form 4 on SEC.gov

Kovacs Shane William Charles

CH. OPERATING & FINANCIAL OFF.

Sale

日期

Jan 13

股数

3,822

均价

$28.01

总金额

$107K

View Form 4 on SEC.gov

Kovacs Shane William Charles

CH. OPERATING & FINANCIAL OFF.

Sale

日期

Jan 15

股数

100,000

均价

$28.73

总金额

$2.87M ⚡

View Form 4 on SEC.gov

Myles David C.

CH. DISCOV. & NON-CLIN DEV OFF

Option

日期

Jan 14

股数

50,000

均价

$4.87

总金额

$244K

View Form 4 on SEC.gov

Myles David C.

CH. DISCOV. & NON-CLIN DEV OFF

Sale

日期

Jan 14

股数

14,997

均价

$28.60

总金额

$429K

View Form 4 on SEC.gov

Myles David C.

CH. DISCOV. & NON-CLIN DEV OFF

Sale

日期

Jan 13

股数

49,800

均价

$27.60

总金额

$1.37M ⚡

View Form 4 on SEC.gov

Myles David C.

CH. DISCOV. & NON-CLIN DEV OFF

Sale

日期

Jan 14

股数

35,003

均价

$28.99

总金额

$1.01M ⚡

View Form 4 on SEC.gov

Myles David C.

CH. DISCOV. & NON-CLIN DEV OFF

Sale

日期

Jan 13

股数

200

均价

$28.49

总金额

$6K

View Form 4 on SEC.gov

Myles David C.

CH. DISCOV. & NON-CLIN DEV OFF

Sale

日期

Jan 12

股数

10,000

均价

$28.34

总金额

$283K

View Form 4 on SEC.gov

Bohen Sean

President and CEO · Director

Gift

日期

Dec 26

股数

8,500

均价

—

总金额

—

View Form 4 on SEC.gov

Harmon Cyrus

Director

Sale

日期

Dec 22

股数

2,881

均价

$28.53

总金额

$82K

View Form 4 on SEC.gov

CLARK IAN T

Director

Option

日期

Dec 19

股数

12,070

均价

$4.08

总金额

$49K

View Form 4 on SEC.gov

CLARK IAN T

Director

Option

日期

Dec 19

股数

21,520

均价

$7.84

总金额

$169K

View Form 4 on SEC.gov

CLARK IAN T

Director

Sale

日期

Dec 19

股数

29,904

均价

$28.83

总金额

$862K

View Form 4 on SEC.gov

CLARK IAN T

Director

Option

日期

Dec 19

股数

21,520

均价

$3.61

总金额

$78K

View Form 4 on SEC.gov

CLARK IAN T

Director

Option

日期

Dec 19

股数

209,690

均价

$4.41

总金额

$924K

View Form 4 on SEC.gov

CLARK IAN T

Director

Sale

日期

Dec 19

股数

193,056

均价

$29.71

总金额

$5.74M ⚡

View Form 4 on SEC.gov

CLARK IAN T

Director

Sale

日期

Dec 19

股数

41,840

均价

$30.48

总金额

$1.28M ⚡

View Form 4 on SEC.gov

Myles David C.

CH. DISCOV. & NON-CLIN DEV OFF

Sale

日期

Dec 19

股数

1,225

均价

$28.08

总金额

$34K

View Form 4 on SEC.gov

⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股

1 / 2

▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —

关于 OLMA 内幕交易

OLMA 内幕交易

Olema Pharmaceuticals, Inc.（OLMA）内幕交易数据来源于公司内部人（包括Myles David C. (CH. DISCOV. & NON-CLIN DEV OFF), Zojwalla Naseem (Chief Medical Officer), Harmon Cyrus (Director)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。OLMA内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。

如需查看Olema Pharmaceuticals, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →

买卖信号逻辑

acquisitionOrDisposition字段：

A = 买入 · D = 卖出（处置）

RSU归属（M-Exempt）不计入情绪判断

Form 4SEC要求内部人在任何交易后2个工作日内提交的申报文件

10b5-1预设交易计划，允许内部人按计划自动卖出

Open Mkt公开市场直接买卖（不含股权奖励和期权行权）

机构持仓 SEC 申报财务报表价格历史预测与评级财报

常见问题

OLMA 内幕交易 · 5个问题

Olema Pharmaceuticals, Inc.（OLMA）的内部人包括高管和董事，如Myles David C. (CH. DISCOV. & NON-CLIN DEV OFF), Zojwalla Naseem (Chief Medical Officer), Harmon Cyrus (Director)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。

OLMA 董事内幕交易OLMA 内部人名单Olema Pharmaceuticals, Inc. 高管内幕活动

▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026